These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16814307)

  • 1. Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.
    Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V
    J Chromatogr A; 2006 Aug; 1123(1):130-3. PubMed ID: 16814307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.
    Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V
    Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
    Salgado-Petinal C; Lamas JP; Garcia-Jares C; Llompart M; Cela R
    Anal Bioanal Chem; 2005 Jul; 382(6):1351-9. PubMed ID: 15986209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry.
    Maurer HH; Bickeboeller-Friedrich J
    J Anal Toxicol; 2000; 24(5):340-7. PubMed ID: 10926357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography.
    Unceta N; Gómez-Caballero A; Sánchez A; Millán S; Sampedro MC; Goicolea MA; Sallés J; Barrio RJ
    J Pharm Biomed Anal; 2008 Mar; 46(4):763-70. PubMed ID: 18222055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study.
    Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V; Buitrago S
    J Sep Sci; 2006 Jan; 29(1):103-13. PubMed ID: 16485715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrays of SnO2 nanorods as novel solid phase microextraction for trace analysis of antidepressant drugs in body fluids.
    Alizadeh R; Najafi NM; Poursani EM
    J Pharm Biomed Anal; 2012 Nov; 70():492-8. PubMed ID: 22877874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography-mass spectrometry detection of a norfluoxetine artifact in hydrolyzed urine samples may falsely indicate tranylcypromine ingestion.
    Schwaninger AE; Meyer MR; Maurer HH
    J Anal Toxicol; 2010; 34(1):45-8. PubMed ID: 20109302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.
    Kristoffersen L; Bugge A; Lundanes E; Slørdal L
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):229-46. PubMed ID: 10595721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Eap CB; Bouchoux G; Amey M; Cochard N; Savary L; Baumann P
    J Chromatogr Sci; 1998 Jul; 36(7):365-71. PubMed ID: 9679303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data.
    Idborg H; Edlund PO; Jacobsson SP
    Rapid Commun Mass Spectrom; 2004; 18(9):944-54. PubMed ID: 15116421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive determination of Fluoxetine and Citalopram antidepressants in urine and wastewater samples by liquid chromatography coupled with photodiode array detector.
    Sarıkaya M; Ulusoy HI; Morgul U; Ulusoy S; Tartaglia A; Yılmaz E; Soylak M; Locatelli M; Kabir A
    J Chromatogr A; 2021 Jul; 1648():462215. PubMed ID: 34000593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar electrokinetic capillary chromatography for the determination of fluoxetine and its metabolite norfluoxetine in biological fluids.
    Berzas Nevado JJ; Contento Salcedo AM; Villaseñor Llerena MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):261-8. PubMed ID: 11996492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K
    Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
    Unceta N; Goicolea MA; Barrio RJ
    Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiresidue pesticide analysis of ginseng powders using acetonitrile- or acetone-based extraction, solid-phase extraction cleanup, and gas chromatography-mass spectrometry/selective ion monitoring (GC-MS/SIM) or -tandem mass spectrometry (GC-MS/MS).
    Wong JW; Zhang K; Tech K; Hayward DG; Krynitsky AJ; Cassias I; Schenck FJ; Banerjee K; Dasgupta S; Brown D
    J Agric Food Chem; 2010 May; 58(10):5884-96. PubMed ID: 20225896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography-electrospray mass spectrometry for therapeutic drug monitoring.
    Ansermot N; Brawand-Amey M; Eap CB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():117-30. PubMed ID: 22285965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive, high-throughput gas chromatographic-mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies.
    Addison RS; Franklin ME; Hooper WD
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):153-60. PubMed ID: 9824228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of selective serotonin reuptake inhibitors in plasma and urine by micellar liquid chromatography coupled to fluorescence detection.
    Agrawal N; Esteve-Romero J; Bose D; Dubey NP; Peris-Vicente J; Carda-Broch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():142-9. PubMed ID: 25023211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
    Juan H; Zhiling Z; Huande L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):33-9. PubMed ID: 15866490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.